EP0550595A4 - Methods - Google Patents

Methods

Info

Publication number
EP0550595A4
EP0550595A4 EP19910917436 EP91917436A EP0550595A4 EP 0550595 A4 EP0550595 A4 EP 0550595A4 EP 19910917436 EP19910917436 EP 19910917436 EP 91917436 A EP91917436 A EP 91917436A EP 0550595 A4 EP0550595 A4 EP 0550595A4
Authority
EP
European Patent Office
Prior art keywords
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP19910917436
Other versions
EP0550595A1 (en
Inventor
Alison Mary Badger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Anormed Inc
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of EP0550595A1 publication Critical patent/EP0550595A1/en
Publication of EP0550595A4 publication Critical patent/EP0550595A4/en
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EP19910917436 1990-09-24 1991-09-18 Methods Ceased EP0550595A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58732290A 1990-09-24 1990-09-24
US587322 1990-09-24

Publications (2)

Publication Number Publication Date
EP0550595A1 EP0550595A1 (en) 1993-07-14
EP0550595A4 true EP0550595A4 (en) 1993-09-08

Family

ID=24349331

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19910917436 Ceased EP0550595A4 (en) 1990-09-24 1991-09-18 Methods

Country Status (5)

Country Link
EP (1) EP0550595A4 (en)
JP (1) JPH06501468A (en)
AU (1) AU652583B2 (en)
CA (1) CA2092177A1 (en)
WO (1) WO1992004899A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9201803D0 (en) * 1992-01-28 1992-03-11 Smithkline Beecham Corp Methods
GB9217116D0 (en) * 1992-08-13 1992-09-23 Smithkline Beecham Corp Methods
SK156698A3 (en) * 1996-05-17 1999-06-11 Anormed Inc Use of substituted azaspirane in the treatment of asthma

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4963557A (en) * 1987-09-28 1990-10-16 Smithkline Beecham Corporation Immunomodulatory azaspiranes

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY vol. 11, no. 7, 1989, pages 839 - 846 BADGER, A.M. ET AL 'INHIBITION OF ANIMAL MODELS OF AUTOIMMUNE DISEASE AND THE INDUCTION OF NON-SPECIFIC SUPPRESSOR CELLS BY SK&F 105685 AND RELATED AZASPIRANES' *
JOURNAL OF AUTOIMMUNITY vol. 6, no. 1, February 1993, pages 39 - 49 RABINOVITCH, A. ET AL 'PREVENTION OF DIABETES AND INDUCTION OF NON-SPECIFIC SUPPRESSOR CELL ACTIVITY IN THE BB RAT BY AN IMMUNOMODULATORY AZASPIRANE, SK&F 106610' *
JOURNAL OF MEDICINAL CHEMISTRY vol. 33, no. 11, November 1990, pages 2963 - 2970 BADGER, A.M. ET AL 'ANTIARTHRITIC AND SUPPRESSOR CELL INDUCING ACTIVITY OF AZASPIRANES: STRUCTURE-FUNCTION RELATIONSHIPS OF A NOVEL CLASS OF IMMUNOMODULATORY AGENTS' *
See also references of WO9204899A1 *

Also Published As

Publication number Publication date
WO1992004899A1 (en) 1992-04-02
CA2092177A1 (en) 1992-03-25
AU652583B2 (en) 1994-09-01
EP0550595A1 (en) 1993-07-14
JPH06501468A (en) 1994-02-17
AU8631091A (en) 1992-04-15

Similar Documents

Publication Publication Date Title
DE4190756D2 (en) Mikrotom
DE69125252D1 (en) Röntgentherapie-simulatormachine
EP0440282A3 (en) Sensormatrix
DE69126781D1 (en) Fabry-perot-modulator
EP0463302A3 (en) Pinchcock
DE69116171D1 (en) Photo- und biologisch-abbaubare polyethen-copolymere
DE69127252D1 (en) Linearlager
EP0465262A3 (en) Polysilethylenesiloxane
DE4092449D2 (en) Taschenfederkernmatratze
EP0465263A3 (en) Polysilethylenesiloxane
EP0442596A3 (en) Echelle-polychromator
DE4191708D2 (en) Festkoerperlaser
AU111085S (en) Sunlounger
EP0467207A3 (en) Purinderivate
EP0458340A3 (en) Slitterscorer
CS262591A3 (en) Indolonaphthyridines
EP0444458A3 (en) Pulsdopplerradar
EP0441276A3 (en) Electrophotoreceptor
DE4092685D2 (en) Mehrkomponenten-kleb- und -werkstoffverarbeitungssystem
EP0464900A3 (en) 2-biphenyl-carbapenems
EP0447954A3 (en) Spray-station
EP0550595A4 (en) Methods
EP0439820A3 (en) Vacuumswitch
EP0442371A3 (en) Bisglycosides
EP0455870A3 (en) Laboratory-centrifuge

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19930325

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE

A4 Supplementary search report drawn up and despatched

Effective date: 19930720

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE

17Q First examination report despatched

Effective date: 19950911

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: ANORMED INC

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

RTI1 Title (correction)

Free format text: USE OF AZASPIRANES FOR THE MANUFACTURE OF A MEDIAMENT FOR THE TREATMENT OF DISEASES CAUSED BY EXCESSIVE GLUCOSE LEVELS

RTI1 Title (correction)

Free format text: USE OF AZASPIRANES FOR THE MANUFACTURE OF A MEDIAMENT FOR THE TREATMENT OF DISEASES CAUSED BY EXCESSIVE GLUCOSE LEVELS

RTI1 Title (correction)

Free format text: USE OF AZASPIRANES FOR THE MANUFACTURE OF A MEDIAMENT FOR THE TREATMENT OF DISEASES CAUSED BY EXCESSIVE GLUCOSE LEVELS

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20000101

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1012271

Country of ref document: HK